Page 8 - Stroke Statistics News Today

MADISON, June 1, 2023 — Seven in 10 people in America say they feel powerless to act in the face of a cardiac emergency[1]. As a result, less than half o

Holter Monitoring Systems Market, By End User (Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers), By Product (Event Monitoring Devices,

Comprehensive in-hospital planning, postdischarge follow-up, ongoing support are key.

— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — --Data Further Advances Understanding of VASCEPA/VAZKEPA... | May 12, 2023

AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death, hospitalisation for heart failure (hHF) and urgent heart failure (HF) visits in adults with HF. The approval by the Food and Drug Administration (FDA) was based on positive results from the DELIVER ...

Beyond Steak’s nutrition profile meets the distinguished and trusted Heart-Check Mark criteria from the American Heart Association, which certifies products based on heart-healthy nutrition... | May 9, 2023

FDA approval means patients with heart failure can benefit from FARXIGA regardless of left ventricular ejection fraction status ... | May 9, 2023

(Family Features) — The same risk factors that contribute to making heart disease the leading cause of death worldwide also impact the rising gl

The risks for COVID-19 have faded so much from everyday American life that some experts are concerned people dont fully realize it remains one of the leading causes of death in the US.

Complete Response Letter States that GALACTIC-HF Alone Does not Establish Substantial Evidence of Effectiveness Sufficient for Approval Company Expects to...